|
Mr. Culp has served as President and Chief Executive Officer of Danaher since May 2001. During his tenure as CEO, Danaher has established leadership positions in the Medical Technologies and Product Identification markets while more than doubling total revenues to nearly $10B.
Mr. Culp began his Danaher career in 1990 at Veeder-Root where he became President in 1993. He subsequently became a Group Executive and Corporate Officer in 1995 where he had primary leadership responsibility for Danaher's Environmental and Electronic Test businesses. In 1999 he was appointed Executive Vice President and became Chief Operating Officer in 2000.
Throughout his Danaher career, he has played a key role in the development and application of the Danaher Business System.
Prior to joining Danaher, Mr. Culp held positions with Accenture.
Mr. Culp is a member of the Board of Directors for GlaxoSmithKline, plc. and on the Board of Visitors and Governors for Washington College.
Mr. Culp earned his B.A. from Washington College and his MBA from Harvard Business School. | 